Shares of Evoke plc (LON:EVOK – Get Free Report) dropped 10% during trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Upgrades and Downgrades
EVOK has been the subject of several research reports. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a report on Monday, December 16th. Berenberg Bank cut their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research report on Wednesday, December 4th.
Get Our Latest Analysis on EVOK
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, equities analysts expect that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Transactions at Evoke
In other Evoke news, insider Andrea Gisle Joosen bought 14,572 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were bought at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
Evoke Company Profile
See Also
- Five stocks we like better than Evoke
- 3 Fintech Stocks With Good 2021 Prospects
- MarketBeat Week in Review – 03/24 – 03/28
- 3 Tickers Leading a Meme Stock Revival
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- A Deeper Look at Bid-Ask Spreads
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.